Search Results

Lone Star Bio

The Ingredient Transparency Center’s Collagen Stewardship Alliance Adds BioCell Technology to its Supporter List

Today, the Ingredient Transparency Center’s Collagen Stewardship Alliance (CSA) announced that BioCell Technology, LLC has signed on as a Sponsor Level supporter.

July 15, 2021

·

3 min read

FDA

Genea Biocells Announces FDA Orphan Drug Designation for GBC0905 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)

This small molecule agent potently suppresses DUX4 function, the molecular cause of the disease.

May 31, 2018

·

5 min read

Pharm Country

Parker Waichman LLP is Reviewing Allergan’s BIOCELL textured breast implants and Allergan’s BIOCELL Breast Tissue Expander Lymphoma Cases

Allergan issued a worldwide recall of its BIOCELL textured breast implants and BIOCELL tissue expanders following reports of women being diagnosed with cancer, with some cases resulting in death.

July 29, 2019

·

2 min read

Biotech Beach

BioCell Technology Announces BioCell Collagen® Skin Aging Clinical Trial Poster Presentation at ASN Nutrition 2019

Dietary supplementation with BioCell Collagen® significantly reduced facial lines and wrinkles, crow’s feet lines/wrinkles, increased skin elasticity and cutaneous collagen content, and decreased skin dryness compared to placebo.

June 12, 2019

·

4 min read

Pharm Country

Berger Montague Announces That Many Claims for Injuries Arising from the Recall of Allergan’s BIOCELL Textured Breast Implants Will Now Proceed to Discovery

The national plaintiffs’ law firm Berger Montague is pleased to announce that the U.S. District Court in New Jersey has just issued a 121 page opinion and order in the Allergan BIOCELL Textured Breast Implant Products Liability Litigation, No. 2:19-md-02921, MDL No. 2921 (D.N.J.),

March 23, 2021

·

5 min read

Job Trends

Genea Biocells Expands to the U.S. with New Jobs in SoCal

June 24, 2015

·

3 min read

Biotech Beach

Genea Biocells Publishes First Human Stem Cell Model Of Facioscapulohumeral Muscular Dystrophy (FSHD)

May 24, 2016

·

3 min read

Business

Ziopharm Oncology Announces First Patient Infused in CD19 RPM CAR-T Phase I Clinical Trial Being Conducted by Joint Venture Partner Eden BioCell

Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq: ZIOP), announced today that in March, the first patient was infused in the CD19-Specific Rapid Personalized Manufacturing (“RPM”) CAR-T Phase I Trial, being conducted by Eden BioCell, its joint venture with TriArm Therapeutics.

April 19, 2021

·

4 min read

Press Releases

Complete Genomics announces Gene by Gene as its newest sequencing service provider at ASHG

October 14, 2025

·

2 min read

Press Releases

Hydrosome Labs Reveals Promising Fermentation Breakthrough Using Ultrafine Bubbles

September 10, 2025

·

2 min read